New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Dash Xclusive Issues Voluntary Nationwide Recall of Imperia Elita Vitaccino Coffee Due to the Presence of Undeclared Sibutramine and Fluoxetine
Yamtun7 Issues Voluntary Nationwide Recall of Poseidon Platinum 3500 Due to the Presence of Undeclared Tadalafil and Sildenafil
Novo Nordisk Issues Voluntary Nationwide Recall of Levemir®, Tresiba®, Fiasp®, Novolog® and Xultophy® Product Samples Due to Improper Storage Temperature Conditions
FDA Stresses Critical Importance of Safe Disposal of Medications Ahead of National Prescription Drug Take Back Day
For many years, the U.S. Food and Drug Administration has strongly supported work to expand the availability of drug take back programs.
Advancing the Development of Safe and Effective Regenerative Medicine Products
Innovative medical products such as cellular-derived therapies, including stem cell-based products, offer the potential to treat or even cure diseases.
A Year Into the Pandemic: How the FDA’s Center for Devices and Radiological Health is Prioritizing its Workload and Looking Ahead
Since the beginning of the COVID-19 pandemic we have taken steps to attend to the enormous magnitude of COVID-19 related submissions, adopting agile approaches.